Freenome Raises $254M to Accelerate Early Cancer Detection Platform
What You Should Know:
– Freenome, a leader in blood-based early cancer detection, has raised $254M in a new funding round, fueled by its innovative multiomics platform and promising pipeline of tests. The funding was…
Continue Reading